SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ming-Ling Chang, Wen-Juei Jeng, Yun-Fan Liaw, Clinical Events After Cessation of Lamivudine Therapy in Patients Recovered From Hepatitis B Flare With Hepatic Decompensation, Clinical Gastroenterology and Hepatology, 2015, 13, 5, 979

    CrossRef

  2. 2
    Shinya Nagaoka, Seigo Abiru, Atsumasa Komori, Ryu Sasaki, Shigemune Bekki, Satoru Hashimoto, Akira Saeki, Kazumi Yamasaki, Kiyoshi Migita, Minoru Nakamura, Hironori Ezaki, Hiroshi Yatsuhashi, Hepatic flares promote rapid decline of serum hepatitis B surface antigen (HBsAg) in patients with HBsAg seroclearance: A long-term follow-up study, Hepatology Research, 2015, 45, 8
  3. 3
    Haruki Komatsu, Ayano Inui, Hepatitis B virus infection in children, Expert Review of Anti-infective Therapy, 2015, 1

    CrossRef

  4. 4
    Eleanor Barnes, Therapeutic vaccines in HBV: lessons from HCV, Medical Microbiology and Immunology, 2015, 204, 1, 79

    CrossRef

  5. 5
    M.-C. Tsai, C.-H. Chen, C.-H. Hung, C.-M. Lee, K.-W. Chiu, J.-H. Wang, S.-N. Lu, P.-L. Tseng, K.-C. Chang, Y.-H. Yen, T.-H. Hu, A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match–control study, Clinical Microbiology and Infection, 2014, 20, 2
  6. 6
    Wei Jia, Liu-Wei Song, Yu-Qing Fang, Xiao-Feng Wu, Dan-Yang Liu, Chun Xu, Xiao-Mei Wang, Wen Wang, Dong-Xia Lv, Jun Li, Yong-Qiong Deng, Yan Wang, Na Huo, Min Yu, Hong-Li Xi, Dan Liu, Yi-Xing Zhou, Gui-Qiang Wang, Ning-Shao Xia, Ming-Xiang Zhang, Antibody to Hepatitis B Core Antigen Levels in the Natural History of Chronic Hepatitis B, Medicine, 2014, 93, 29, e322

    CrossRef

  7. 7
    Ming-Ling Chang, Yun-Fan Liaw, Hepatitis B flares in chronic hepatitis B: Pathogenesis, natural course, and management, Journal of Hepatology, 2014, 61, 6, 1407

    CrossRef

  8. 8
    Shilpa Chokshi, Helen Cooksley, Antonio Riva, Sandra Phillips, Roger Williams, Anuj Gaggar, Nikolai V. Naoumov, Identification of Serum Cytokine Profiles Associated with HBeAg Seroconversion Following Antiviral Treatment Interruption, Viral Immunology, 2014, 27, 5, 235

    CrossRef

  9. 9
    U. Poddar, S. K. Yachha, J. Agarwal, N. Krishnani, Cure for immune-tolerant hepatitis B in children: is it an achievable target with sequential combo therapy with lamivudine and interferon?, Journal of Viral Hepatitis, 2013, 20, 5
  10. 10
    Turyadi, Meta Dewi Thedja, Susan Irawati Ie, Alida Roswita Harahap, Korri Elvanita El-Khobar, Martono Roni, David Handojo Muljono, HBsAg, HBeAg and HBV DNA level changes and precore/basal core promoter mutations in the natural history of chronic hepatitis B in Indonesian patients, Hepatology International, 2013, 7, 4, 969

    CrossRef

  11. 11
    Brian Lin, Nghiem B Ha, Anne Liu, Huy N Trinh, Huy A Nguyen, Khanh K Nguyen, Aijaz Ahmed, Emmet B Keeffe, Ruel T Garcia, Gabriel Garcia, Mindie H Nguyen, Low incidence of hepatitis B e antigen seroconversion in patients treated with oral nucleos(t)ides in routine practice, Journal of Gastroenterology and Hepatology, 2013, 28, 5
  12. 12
    Cheng-Yuan Peng, Nucleos(t)ide Analogues Therapy for Chronic Hepatitis B in Taiwan: Short-Term Versus Long-Term, Current Hepatitis Reports, 2013, 12, 3, 181

    CrossRef

  13. 13
    Ping Chen, Chengbo Yu, Wei Wu, Jinghua Wang, Bing Ruan, Jingjing Ren, Shigui Yang, Kaijin Xu, Liang Yu, Lanjuan Li, Serolological Profile Among HBsAg-Positive Infections in Southeast China: A Community-Based Study, Hepatitis Monthly, 2013, 13, 1

    CrossRef

  14. 14
    G.-Q. Wang, Y.-P. Ding, Y.-H. Dong, Telbivudine treatment is associated with high hepatitis B e antigen seroconversion and immune modulatory effects in chronic hepatitis B patients, Journal of Viral Hepatitis, 2013, 20,
  15. 15
    M.-C. Tsai, C.-M. Lee, K.-W. Chiu, C.-H. Hung, W.-C. Tung, C.-H. Chen, P.-L. Tseng, K.-C. Chang, J.-H. Wang, S.-N. Lu, Y.-H. Yen, T.-H. Hu, A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice, Journal of Antimicrobial Chemotherapy, 2012, 67, 3, 696

    CrossRef

  16. 16
    Yun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, Henry Lik Yuen Chan, Rong-Nan Chien, Chun-Jen Liu, Ed Gane, Stephen Locarnini, Seng-Gee Lim, Kwang-Hyub Han, Deepak Amarapurkar, Graham Cooksley, Wasim Jafri, Rosmawati Mohamed, Jin-Lin Hou, Wan-Long Chuang, Laurentius A. Lesmana, Jose D. Sollano, Dong-Jin Suh, Masao Omata, Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update, Hepatology International, 2012, 6, 3, 531

    CrossRef

  17. 17
    Hui Won Jang, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Kwang-Hyub Han, Chae Yoon Chon, Young Nyun Park, Eun Hee Choi, Do Young Kim, How Many Valid Measurements Are Necessary to Assess Liver Fibrosis Using FibroScan® in Patients with Chronic Viral Hepatitis? An Analysis of Subjects with at Least 10 Valid Measurements, Yonsei Medical Journal, 2012, 53, 2, 337

    CrossRef

  18. 18
    Hwai–I Yang, Hsiu–Lian Hung, Mei–Hsuan Lee, Jessica Liu, Chin–Lan Jen, Jun Su, Li–Yu Wang, Sheng–Nan Lu, San–Lin You, Uchenna H. Iloeje, Chien–Jen Chen, Incidence and Determinants of Spontaneous Seroclearance of Hepatitis B e Antigen and DNA in Patients With Chronic Hepatitis B, Clinical Gastroenterology and Hepatology, 2012, 10, 5, 527

    CrossRef

  19. 19
    Sung Kwan Bae, Hiroshi Yatsuhashi, Satoru Hashimoto, Yasuhide Motoyoshi, Eisuke Ozawa, Shinya Nagaoka, Seigo Abiru, Atsumasa Komori, Kiyoshi Migita, Minoru Nakamura, Masahiro Ito, Yuzo Miyakawa, Hiromi Ishibashi, Prediction of early HBeAg seroconversion by decreased titers of HBeAg in the serum combined with increased grades of lobular inflammation in the liver, Medical Science Monitor, 2012, 18, 12, CR698

    CrossRef

  20. 20
    Seung Ha Park, Chang Hoon Kim, Dong Joon Kim, Jae Youn Cheong, Sung Won Cho, Seong Gyu Hwang, Youn Jae Lee, Mong Cho, Jin Mo Yang, Young Bae Kim, Development and Validation of a Model to Predict Advanced Fibrosis in Chronic Hepatitis B Virus-Infected Patients with High Viral Load and Normal or Minimally Raised ALT, Digestive Diseases and Sciences, 2011, 56, 6, 1828

    CrossRef

  21. 21
    Lok-Beng Koay, I-Che Feng, Ming-Jen Sheu, Hsing-Tao Kuo, Chin-Yih Lin, Jyh-Jou Chen, Shih-Ling Wang, Ling-Yu Tang, Sun-Lung Tsai, Hepatitis B virus (HBV) core antigen-specific regulatory T cells confer sustained remission to anti-HBV therapy in chronic hepatitis B with acute exacerbation, Human Immunology, 2011, 72, 9, 687

    CrossRef

  22. 22
    Maximilian Lee, Emmet B. Keeffe, Hepatitis B: Modern End Points of Treatment and the Specter of Viral Resistance, Gastroenterology Clinics of North America, 2011, 40, 3, 495

    CrossRef

  23. 23
    Eric C. Han, Ying-Shiung Lee, Yu-Ching Liu, Hsin-Yi Liao, Wen-Sin Liao, Hsueh-Chou Lai, Cheng-Yuan Peng, Long-Bin Jeng, Mass spectrometry-based plasma peptide profiling of acute exacerbation in HBeAg-positive chronic hepatitis B, Clinica Chimica Acta, 2011, 412, 23-24, 2174

    CrossRef

  24. 24
    Cheng-Yuan Peng, Chih-Bin Chen, Hsueh-Chou Lai, Wen-Pang Su, Po-Heng Chuang, Hong-Dar Isaac Wu, Long-Bin Jeng, Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbation, Hepatology International, 2011, 5, 1, 586

    CrossRef

  25. 25
    Ling Yang, Shiwu Ma, Xiaoxiong Hu, Lei Xiao, Zhanhui Wang, Yongyin Li, Bin Zhou, William G.H. Abbott, Jinlin Hou, Presence of valine at position 27 of the hepatitis B virus core gene is associated with severe liver inflammation in Chinese patients, Journal of Medical Virology, 2011, 83, 2
  26. 26
    Akihiro Tamori, Tatsuya Koike, Hitoshi Goto, Shigeyuki Wakitani, Masahiro Tada, Hiroyasu Morikawa, Masaru Enomoto, Masaaki Inaba, Tatsuya Nakatani, Masayuki Hino, Norifumi Kawada, Prospective study of reactivation of hepatitis B virus in patients with rheumatoid arthritis who received immunosuppressive therapy: evaluation of both HBsAg-positive and HBsAg-negative cohorts, Journal of Gastroenterology, 2011, 46, 4, 556

    CrossRef

  27. 27
    J. P. Gisbert, M. Chaparro, M. Esteve, Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, 2011, 33, 6
  28. 28
    Michelle Lai, Yun-Fan Liaw, Chronic Hepatitis B: Past, Present, and Future, Clinics in Liver Disease, 2010, 14, 3, 531

    CrossRef

  29. 29
    Yun-Fan Liaw, George K. K. Lau, Jia-Horng Kao, Edward Gane, Hepatitis B e Antigen Seroconversion: A Critical Event in Chronic Hepatitis B Virus Infection, Digestive Diseases and Sciences, 2010, 55, 10, 2727

    CrossRef

  30. 30
    Wen–Juei Jeng, I–Shyan Sheen, Yun–Fan Liaw, Hepatitis B Virus DNA Level Predicts Hepatic Decompensation in Patients With Acute Exacerbation of Chronic Hepatitis B, Clinical Gastroenterology and Hepatology, 2010, 8, 6, 541

    CrossRef

  31. 31
    MATTHEW EDEY, KATHERINE BARRACLOUGH, DAVID W JOHNSON, Review article: Hepatitis B and dialysis, Nephrology, 2010, 15, 2
  32. 32
    Kuan-Ta Wu, Kun-Ming Chung, I.-Che Feng, Ming-Jen Sheu, Hsing-Tao Kuo, Lok-Beng Koay, Chin-Yih Lin, Ling-Yu Tang, Sun-Lung Tsai, Acute hepatitis E virus infection in Taiwan 2002–2006 revisited: PCR shows frequent co-infection with multiple hepatitis viruses, Journal of Medical Virology, 2009, 81, 10
  33. 33
    Yun-Fan Liaw, Antiviral therapy of chronic hepatitis B: Opportunities and challenges in Asia, Journal of Hepatology, 2009, 51, 2, 403

    CrossRef

  34. 34
    Hakan Senturk, Fehmi Tabak, Resat Ozaras, Levent Erdem, Billur Canbakan, Ali Mert, Ibrahim Yurdakul, Efficacy of Pre-S-containing HBV Vaccine Combined with Lamivudine in the Treatment of Chronic HBV Infection, Digestive Diseases and Sciences, 2009, 54, 9, 2026

    CrossRef

  35. 35
    Bulent Degertekin, Anna S. F. Lok, Indications for therapy in hepatitis B, Hepatology, 2009, 49, S5
  36. 36
    Ming-Jen Sheu, Hsing-Tao Kuo, Ching-Yih Lin, Lok-Beng Koay, Chuan Lee, Jyh-Jou Chen, Ling-Yu Tang, Sun-Lung Tsai, Lamivudine monotherapy for chronic hepatitis B infection with acute exacerbation revisited, European Journal of Gastroenterology & Hepatology, 2009, 21, 4, 447

    CrossRef

  37. 37
    Yun-Fan Liaw, Nancy Leung, Jia-Horng Kao, Teerha Piratvisuth, Edward Gane, Kwang-Hyub Han, Richard Guan, George K. K. Lau, Stephen Locarnini, Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update, Hepatology International, 2008, 2, 3, 263

    CrossRef

  38. 38
    Mario Rizzetto, Alessia Ciancio, Chronic HBV-related liver disease, Molecular Aspects of Medicine, 2008, 29, 1-2, 72

    CrossRef

  39. 39
    Rong-Nan Chien, Yun-Fan Liaw, Nucleos(t)ide analogues for hepatitis B virus: Strategies for long-term success, Best Practice & Research Clinical Gastroenterology, 2008, 22, 6, 1081

    CrossRef

  40. 40
    Rui Gao, Zhuan Liao, Zhao-Shen Li, Scientific publications in gastroenterology and hepatology journals from Chinese authors in various parts of North Asia: 10-year survey of literature, Journal of Gastroenterology and Hepatology, 2008, 23, 3
  41. 41
    Annika Kau, Johannes Vermehren, Christoph Sarrazin, Treatment predictors of a sustained virologic response in hepatitis B and C, Journal of Hepatology, 2008, 49, 4, 634

    CrossRef

  42. 42
    I-Chin Wu, Nan-Haw Chow, Pin-Nan Cheng, Wen-Chun Liu, Kung-Chia Young, Wei-Lun Chang, Chi-Yi Chen, Kuo-Chih Tseng, Ting-Tsung Chang, Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B, Journal of Medical Virology, 2007, 79, 6
  43. 43
    C.-M. Chu, Y.-F. Liaw, Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion, Journal of Viral Hepatitis, 2007, 14, 3
  44. 44
    Yi-Cheng Chen, Chia-Ming Chu, Chau-Ting Yeh, Yun-Fan Liaw, Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study, Hepatology International, 2007, 1, 1, 267

    CrossRef

  45. 45
    Surakit Pungpapong, W. Ray Kim, John J. Poterucha, Natural History of Hepatitis B Virus Infection: An Update for Clinicians, Mayo Clinic Proceedings, 2007, 82, 8, 967

    CrossRef

  46. 46
    Chia–Ming Chu, Yun–Fan Liaw, Predictive Factors for Reactivation of Hepatitis B Following Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B, Gastroenterology, 2007, 133, 5, 1458

    CrossRef

  47. 47
    Hyung Joon Yim, Anna Suk-Fong Lok, Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005, Hepatology, 2006, 43, S1
  48. 48
    Chun-Jen Liu, Pei-Jer Chen, Ming-Yang Lai, Feng-Yi Lin, Tzusan Wang, Jia-Horng Kao, Ding-Shinn Chen, Viral factors correlate with hepatitis B e antigen seroconverson in patients with chronic hepatitis B, Liver International, 2006, 26, 8
  49. 49
    Yun-Fan Liaw, Nancy Leung, Richard Guan, George K.K. Lau, Ismail Merican, Geoff McCaughan, Edward Gane, Jia-Horng Kao, Masao Omata, Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update, Liver International, 2005, 25, 3
  50. 50
    Nobuhiko Hiraga, Fumitaka Suzuki, Norio Akuta, Yoshiyuki Suzuki, Hitomi Sezaki, Tetsuya Hosaka, Takashi Someya, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Marie Matsuda, Sachiko Watabiki, Junko Satoh, Hiromitsu Kumada, Clinical and virological characteristics of untreated patients with chronic hepatitis C who develop serum alanine aminotransferase flare-up, Journal of Medical Virology, 2005, 75, 2
  51. 51
    George K.K. Lau, Teerha Piratvisuth, Kang Xian Luo, Patrick Marcellin, Satawat Thongsawat, Graham Cooksley, Edward Gane, Michael W. Fried, Wan Cheng Chow, Seung Woon Paik, Wen Yu Chang, Thomas Berg, Robert Flisiak, Philip McCloud, Nigel Pluck, Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B, New England Journal of Medicine, 2005, 352, 26, 2682

    CrossRef

  52. 52
    Ming-Ling Chang, Rong-Nan Chien, Chau-Ting Yeh, Yun-Fan Liaw, Virus and transaminase levels determine the emergence of drug resistance during long-term lamivudine therapy in chronic hepatitis B, Journal of Hepatology, 2005, 43, 1, 72

    CrossRef

  53. 53
    Yen-Hsuan Ni, Mei-Hwei Chang, Kuan-Jan Wang, Hong-Yuan Hsu, Huey-Ling Chen, Jia-Horng Kao, Shiou-Hwei Yeh, Yung-Ming Jeng, Keh-Sung Tsai, Ding-Shinn Chen, Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma, Gastroenterology, 2004, 127, 6, 1733

    CrossRef

  54. 54
    TING-TSUNG CHANG, CHING-LUNG LAI, RONG-NAN CHIEN, RICHARD GUAN, SENG-GEE LIM, CHUAN-MO LEE, KENG-YEEN NG, GRAHAM J NICHOLLS, JULIE C DENT, NANCY WY LEUNG, Four years of lamivudine treatment in Chinese patients with chronic hepatitis B, Journal of Gastroenterology and Hepatology, 2004, 19, 11
  55. 55
    Manal H El-Sayed, Alaa El-Haddad, Omar A Fahmy, Iman I Salama, Hossam K Mahmoud, Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation, European Journal of Gastroenterology & Hepatology, 2004, 16, 12, 1347

    CrossRef

  56. 56
    Alfredo Alberti, Giovanna Fattovich, Natural history of chronic hepatitis B, Current Hepatitis Reports, 2004, 3, 2, 54

    CrossRef

  57. 57
    YUN-FAN LIAW, Role of antiviral therapy of HBV in the prevention of cirrhosis and hepatocellular carcinoma, Journal of Gastroenterology and Hepatology, 2004, 19,
  58. 58
    GEOFFREY C FARRELL, Expanding horizons for the Journal: The role of the Journal of Gastroenterology and Hepatology Foundation, Journal of Gastroenterology and Hepatology, 2003, 18, 3
  59. 59
    Yun-Fan Liaw, Results of lamivudine trials in Asia, Journal of Hepatology, 2003, 39, 111

    CrossRef

  60. 60
    Yun-Fan Liaw, Natural History of Chronic Hepatitis B Virus Infection,